Adults with type 1 diabetes who used a GLP-1 receptor agonist or other incretin-based drug had lower risk for all-cause ...

Baystreet.ca News Commentary – The genomics in cancer care market is on a massive tear, projected to hit $69.16 billion by 2032 as doctors ditch one-size-fits-all treatments ...

Nvidia eyes first breakout of 2026. These clues — and an innovative deal with Eli Lilly — bode well.

Obesity took center stage on the first day of the 2026 J.P. Morgan Healthcare Conference, with industry frontrunners Eli ...

Stocks saw their first back-to-back losses of 2026 after an uneventful round of economic data and a batch of earnings from ...

Hippocratic AI has expanded its focus with the acquisition of Grove AI, a specialist in AI used in pharma R&D, to complement ...

Wall Street traders took some risk off the table, with stocks falling and bonds rising amid latest economic data and earnings ...

We talked to experts in obesity, tobacco, artificial intelligence, HIV, TB and the NHI to find out what we can expect — and ...

Illumina has unveiled a database of genomic alterations, called the Billion Cell Atlas, that can be used to identify and ...

Investing.com -- Biogen Inc. ’s new at-home Alzheimer’s drug will provide an advantage over Eli Lilly Co. ’s competing ...

At the JPMorgan Healthcare Conference in San Francisco, drugmakers signalled obesity drugs going mainstream, shifting from ...

Metabolic and bariatric surgery are associated with a reduced risk for adverse kidney outcomes in patients with obesity, ...